Logo image of THMO

THERMOGENESIS HOLDINGS INC (THMO) Stock Fundamental Analysis

NASDAQ:THMO - Nasdaq - US88362L2097 - Common Stock - Currency: USD

0.3102  -0.11 (-25.84%)

After market: 0.3161 +0.01 (+1.9%)

Fundamental Rating

1

THMO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. THMO may be in some trouble as it scores bad on both profitability and health. THMO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year THMO has reported negative net income.
In the past year THMO has reported a negative cash flow from operations.
In the past 5 years THMO always reported negative net income.
In the past 5 years THMO always reported negative operating cash flow.
THMO Yearly Net Income VS EBIT VS OCF VS FCFTHMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

THMO has a worse Return On Assets (-146.23%) than 89.47% of its industry peers.
THMO has a Return On Equity of -1512.82%. This is amonst the worse of the industry: THMO underperforms 88.95% of its industry peers.
Industry RankSector Rank
ROA -146.23%
ROE -1512.82%
ROIC N/A
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
THMO Yearly ROA, ROE, ROICTHMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K -2K

1.3 Margins

THMO's Gross Margin of 21.18% is on the low side compared to the rest of the industry. THMO is outperformed by 80.53% of its industry peers.
In the last couple of years the Gross Margin of THMO has declined.
THMO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
THMO Yearly Profit, Operating, Gross MarginsTHMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

THMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
THMO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for THMO has been increased compared to 5 years ago.
The debt/assets ratio for THMO is higher compared to a year ago.
THMO Yearly Shares OutstandingTHMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
THMO Yearly Total Debt VS Total AssetsTHMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -41.04, we must say that THMO is in the distress zone and has some risk of bankruptcy.
THMO has a Altman-Z score of -41.04. This is amonst the worse of the industry: THMO underperforms 93.68% of its industry peers.
THMO has a Debt/Equity ratio of 4.31. This is a high value indicating a heavy dependency on external financing.
THMO has a worse Debt to Equity ratio (4.31) than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Altman-Z -41.04
ROIC/WACCN/A
WACC17.38%
THMO Yearly LT Debt VS Equity VS FCFTHMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

THMO has a Current Ratio of 0.52. This is a bad value and indicates that THMO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.52, THMO is not doing good in the industry: 96.84% of the companies in the same industry are doing better.
A Quick Ratio of 0.37 indicates that THMO may have some problems paying its short term obligations.
With a Quick ratio value of 0.37, THMO is not doing good in the industry: 97.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.37
THMO Yearly Current Assets VS Current LiabilitesTHMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

THMO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.70%, which is quite impressive.
Looking at the last year, THMO shows a decrease in Revenue. The Revenue has decreased by -7.66% in the last year.
Measured over the past years, THMO shows a decrease in Revenue. The Revenue has been decreasing by -0.47% on average per year.
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%

3.2 Future

The Earnings Per Share is expected to grow by 16.39% on average over the next years. This is quite good.
The Revenue is expected to grow by 20.88% on average over the next years. This is a very strong growth
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
THMO Yearly Revenue VS EstimatesTHMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M
THMO Yearly EPS VS EstimatesTHMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600 -800

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for THMO. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 1.52, the valuation of THMO can be described as very cheap.
THMO's Price/Forward Earnings ratio is rather cheap when compared to the industry. THMO is cheaper than 100.00% of the companies in the same industry.
THMO is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.52
THMO Price Earnings VS Forward Price EarningsTHMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
THMO Per share dataTHMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3 -4

4.3 Compensation for Growth

THMO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
THMO's earnings are expected to grow with 27.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.3%
EPS Next 3Y27.71%

More info and screens

0

5. Dividend

5.1 Amount

THMO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THERMOGENESIS HOLDINGS INC

NASDAQ:THMO (6/14/2024, 8:00:01 PM)

After market: 0.3161 +0.01 (+1.9%)

0.3102

-0.11 (-25.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-17 2024-05-17/amc
Earnings (Next)08-08 2024-08-08/amc
Inst Owners0.02%
Inst Owner Change-99.93%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.47M
Analysts82.86
Price Target5.1 (1544.1%)
Short Float %0.01%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9460.78%
Min EPS beat(2)-14311.8%
Max EPS beat(2)-4609.8%
EPS beat(4)0
Avg EPS beat(4)-7128.85%
Min EPS beat(4)-14311.8%
Max EPS beat(4)-572.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.48%
Min Revenue beat(2)-33.57%
Max Revenue beat(2)-29.39%
Revenue beat(4)0
Avg Revenue beat(4)-36.28%
Min Revenue beat(4)-51.56%
Max Revenue beat(4)-29.39%
Revenue beat(8)0
Avg Revenue beat(8)-30.38%
Revenue beat(12)2
Avg Revenue beat(12)-26.36%
Revenue beat(16)2
Avg Revenue beat(16)-30.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.52
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 2.53
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)-4.28
EYN/A
EPS(NY)0.2
Fwd EY65.76%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS1.21
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.23%
ROE -1512.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.18%
FCFM N/A
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
F-Score3
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.17%
Cap/Sales 10.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.37
Altman-Z -41.04
F-Score3
WACC17.38%
ROIC/WACCN/A
Cap/Depr(3y)69.46%
Cap/Depr(5y)46.66%
Cap/Sales(3y)7.71%
Cap/Sales(5y)4.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%
EBIT growth 1Y-0.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.2%
OCF growth 3YN/A
OCF growth 5YN/A